These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 34533850
1. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Shomali W, Gotlib J. Am J Hematol; 2022 Jan 01; 97(1):129-148. PubMed ID: 34533850 [Abstract] [Full Text] [Related]
2. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. Shomali W, Gotlib J. Am J Hematol; 2019 Oct 01; 94(10):1149-1167. PubMed ID: 31423623 [Abstract] [Full Text] [Related]
3. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management. Gotlib J. Am J Hematol; 2017 Nov 01; 92(11):1243-1259. PubMed ID: 29044676 [Abstract] [Full Text] [Related]
4. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management. Gotlib J. Am J Hematol; 2015 Nov 01; 90(11):1077-89. PubMed ID: 26486351 [Abstract] [Full Text] [Related]
5. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. Shomali W, Gotlib J. Am J Hematol; 2024 May 01; 99(5):946-968. PubMed ID: 38551368 [Abstract] [Full Text] [Related]
6. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management. Gotlib J. Am J Hematol; 2014 Mar 01; 89(3):325-37. PubMed ID: 24577808 [Abstract] [Full Text] [Related]
7. World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management. Gotlib J. Am J Hematol; 2012 Sep 01; 87(9):903-14. PubMed ID: 22926771 [Abstract] [Full Text] [Related]
8. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Gotlib J. Am J Hematol; 2011 Aug 01; 86(8):677-88. PubMed ID: 21761433 [Abstract] [Full Text] [Related]
9. Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Tefferi A, Gotlib J, Pardanani A. Mayo Clin Proc; 2010 Feb 01; 85(2):158-64. PubMed ID: 20053713 [Abstract] [Full Text] [Related]
10. Myeloid neoplasms with eosinophilia. Reiter A, Gotlib J. Blood; 2017 Feb 09; 129(6):704-714. PubMed ID: 28028030 [Abstract] [Full Text] [Related]
11. Causes of hypereosinophilia in 100 consecutive patients. Moller D, Tan J, Gauiran DTV, Medvedev N, Hudoba M, Carruthers MN, Dehghan N, van den Berghe J, Bruyère H, Chen LYC. Eur J Haematol; 2020 Sep 09; 105(3):292-301. PubMed ID: 32364630 [Abstract] [Full Text] [Related]
19. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. Ogbogu PU, Bochner BS, Butterfield JH, Gleich GJ, Huss-Marp J, Kahn JE, Leiferman KM, Nutman TB, Pfab F, Ring J, Rothenberg ME, Roufosse F, Sajous MH, Sheikh J, Simon D, Simon HU, Stein ML, Wardlaw A, Weller PF, Klion AD. J Allergy Clin Immunol; 2009 Dec 09; 124(6):1319-25.e3. PubMed ID: 19910029 [Abstract] [Full Text] [Related]
20. [Characteristics of cytogenetics and molecular biology in patients with eosinophilia]. Qu SQ, Ai XF, Li CW, Li QH, Xu ZF, Qin TJ, Zhang Y, Xiao ZJ. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct 09; 20(5):1216-20. PubMed ID: 23114151 [Abstract] [Full Text] [Related] Page: [Next] [New Search]